Pharma companies gear up for the 'new normal' as they train and align their sales forces for a paradigm shift. GSK leads the charge with staggered return-to-work, others plans yoga sessions and......
Pharma major Dr Reddy's Laboratories on Wednesday reported 52 per cent jump in net profit at Rs 550.39 crore (Rs 5.5 billion) for the first quarter ended June 30, on the back of North American......
Dr Reddy’s Laboratories (DRL) has surged nearly 21% from its closing low of Rs 1,737.60 on March 01, 2013 on the back of increased traction in approvals from the US Food and Drug......
Already having a deal with GlaxoSmithKline for marketing its products in various emerging markets, Dr Reddy's Laboratories had this week inked an agreement to buy the latter's oral penicillin......